Pfizer Planning To Start Phase III DMD Gene Therapy Trial, With Safety Monitoring Protocols

 
• By Jessica Merrill
  
Caution sign
Positive efficacy signals but safety risks too with Pfizer's DMD gene therapy • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from Advanced Therapies